Suppr超能文献

大型医疗保健机构中泌尿妇科手术后阿片类药物处方的评估:我们的处方量有多少?

Evaluation of Opioid Prescriptions After Urogynecologic Surgery Within a Large Health Care Organization: How Much Are We Prescribing?

作者信息

Buono Kristen, Brueseke Taylor, Wu Jun, Whitcomb Emily

机构信息

Division of Biostatistics, Department of Research and Evaluation, Kaiser Permanente, Pasadena.

Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Southern California Permanente Medical Group, Irvine, CA.

出版信息

Female Pelvic Med Reconstr Surg. 2019 Mar/Apr;25(2):125-129. doi: 10.1097/SPV.0000000000000657.

Abstract

OBJECTIVES

Data regarding postoperative opioid prescriptions for patients undergoing urogynecologic surgery are sparse. Our objective was to quantify surgeon prescribing patterns for patients undergoing surgery for pelvic organ prolapse or stress urinary incontinence.

METHODS

Patients who underwent surgery for pelvic organ prolapse or SUI within a large health care maintenance organization were identified by procedural codes within the electronic medical record. Medical records were reviewed for demographic and clinical data. Our primary objective was to describe initial postoperative morphine milligram equivalent (MME) dosages for patients undergoing various urogynecologic surgeries. Secondary objectives were to evaluate rates of postoperative non-opioid analgesic prescriptions, presence of additional postoperative opioid prescriptions within 90 days of surgery, and to characterize prescribing patterns of surgeons from different specialties.

RESULTS

We evaluated 855 patients undergoing 7 urogynecologic surgeries. There was wide variation in the quantity of MME prescribed to patients undergoing different urogynecologic surgeries, and the mean MME ranged from 137.6 mg after a colpocleisis to 214.1 mg after a laparoscopic uterosacral ligament suspension. Less than two thirds of patients received a postoperative nonsteroidal anti-inflammatory drug (NSAID) prescription, and rates of NSAID prescriptions varied widely between surgeons from different specialties. Thirty-nine (4.6%) patients received an additional postoperative opioid prescription specifically for the indication of persistent postoperative pain.

CONCLUSIONS

There is wide variation in the range of MME prescribed postoperatively to patients undergoing common urogynecologic surgeries. Less than two thirds of patients received a postoperative NSAID prescription, which was found to be independently associated with a higher postoperative opioid prescription dose.

摘要

目的

关于接受泌尿妇科手术患者术后阿片类药物处方的数据稀少。我们的目的是量化接受盆腔器官脱垂或压力性尿失禁手术患者的外科医生处方模式。

方法

通过电子病历中的程序代码识别在大型医疗保健维护组织内接受盆腔器官脱垂或压力性尿失禁手术的患者。审查病历以获取人口统计学和临床数据。我们的主要目的是描述接受各种泌尿妇科手术患者术后初始吗啡毫克当量(MME)剂量。次要目的是评估术后非阿片类镇痛药处方率、术后90天内额外阿片类药物处方的存在情况,并描述不同专科外科医生的处方模式。

结果

我们评估了855例接受7种泌尿妇科手术的患者。接受不同泌尿妇科手术的患者所开具的MME数量差异很大,平均MME范围从阴道闭合术后的137.6毫克到腹腔镜子宫骶骨韧带悬吊术后的214.1毫克。不到三分之二的患者接受了术后非甾体抗炎药(NSAID)处方,不同专科外科医生的NSAID处方率差异很大。39例(4.6%)患者专门因术后持续疼痛的指征而接受了额外的术后阿片类药物处方。

结论

接受常见泌尿妇科手术的患者术后开具的MME范围差异很大。不到三分之二的患者接受了术后NSAID处方,发现这与较高的术后阿片类药物处方剂量独立相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验